In recent SARS-Cov-2-induced COVID-19, treatment with G-CSF is not recommended even though COVID-19 is associated with neutropenia because of G-CSF-induced inflammation outcomes (Lazarus and Gale, 2021). The gene discussed is CSF3; the disease is Decreased total neutrophil count.